AGP Executive Report
Last update: 8 hours agoSwiss Health Policy & Pharma: Swissinfo reports regulators are probing whether obesity awareness campaigns by pharma firms (including Eli Lilly) breach rules on advertising prescription-only medicines to the public, with Swissmedic launching an investigation and France fining companies for indirect promotion. Reproductive Health: A University of Zurich and Zurich University Hospital study finds sperm quality in Swiss army recruits has stayed stable since 2005–2017, with 2021 data showing fewer men below WHO sperm-count standards than earlier cohorts. Men’s Health & Substance Use: A University of Geneva study links cannabis use in young Swiss men to about 23% higher testosterone, while stressing the fertility impact remains unclear. Dermatology & Beauty Industry: Incanthera PLC acquired Swiss skincare brand Énielle in an all-share deal and named a new CEO, sending shares up 21%. Healthcare Business: Mediclinic reported revenue and earnings growth while navigating restructuring, including large non-cash impairment charges tied to Switzerland assets. Legal/Health-Adjacent Court Case: A court in Nyon heard allegations that Australian racing driver Joey Mawson sexually assaulted a nurse at Michael Schumacher’s Swiss mansion; Mawson denies wrongdoing. Public Health & Safety: Swiss microbots are reported as repairing spinal cords with stem cells, pointing to new directions in regenerative care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
